Thus, our findings suggested that blockade of miR-150 retards breast cancer development in vivo, probably by inhibiting proliferation and inducing apoptosis of cancer cells via P2X7 receptor up-regulation. The gene discussed is P2RX7; the disease is breast carcinoma.